Hepatocellular carcinoma (HCC) presents significant treatment challenges despite
considerable advancements in its management. The Indian National Association for the …

Background Several treatments are available for treatment of early and very early-stage
Hepatocellular Carcinoma, also known as small Hepatocellular Carcinoma (SHCC) …

Objective: To assess the efficacy and outcomes of percutaneous ablative therapies for
hepatocellular carcinoma (HCC) in the caudate lobe. Methods: Patients within Milan criteria …

Objective: Tumor location is a critical factor for determining technical success and local
recurrence following percutaneous ablation of hepatocellular carcinomas (HCC). The …

Background Recent studies from both India and outside India have shown a change in the
etiological profile of hepatocellular carcinoma (HCC). We aimed to analyze the etiological …

Radiofrequency ablation (RFA) is an alternative treatment for early-stage hepatocellular
carcinoma (HCC). The production of gas bubbles by RFA indicates threshold temperature of …

Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and
affects patients of all genders, races, ethnicities, and socioeconomic status. While the …

Background: Hepatocellular carcinoma (HCC) is a lethal cancer. Two biomarkers were used
for HCC diagnosis including alpha-fetoprotein (AFP) and protein induced by vitamin K …

Introduction Percutaneous radiofrequency ablation (RFA) is a standard treatment for small-
HCC (< 3cm). However, some features such as proximity to intrahepatic vascular structures …

Backgound and Objectives: The treatments of choice for patients with early-stage
hepatocellular carcinoma (HCC) are surgical resection, local ablation therapy, and liver …